Epidemiology of perioperative anaphylaxis

Presse Medicale

Volumn 45, Issue 9, 2016, Pages 758-767

  Mertes, Paul Michel ^a   Volcheck, Gerald W ^b   Garvey, Lene H ^d   Takazawa, Tonomori ^c   Platt, Peter R ^e   Guttormsen, Anne B ^f   Tacquard, Charles ^a  

^a HÔPITAL CIVIL   (France)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; ATRACURIUM BESILATE; CHLORHEXIDINE; ETOMIDATE; HYPNOTIC AGENT; IMMUNOGLOBULIN E; KETAMINE; LATEX; LOCAL ANESTHETIC AGENT; MIDAZOLAM; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; SUGAMMADEX; SUXAMETHONIUM; TUBOCURARINE CHLORIDE; ANESTHETIC AGENT;

ALLERGIC REACTION; ANAPHYLAXIS; ANESTHESIA; BASOPHIL; CLINICAL PRACTICE; COLLOID; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FAINTNESS; GEOGRAPHIC DISTRIBUTION; HEART ARREST; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; MAST CELL; MEDICAL SOCIETY; MORTALITY; PATHOPHYSIOLOGY; PERIOPERATIVE ANAPHYLAXIS; SHORT SURVEY; SKIN TEST; STRUCTURE ACTIVITY RELATION; SYSTEMATIC REVIEW; INTRAOPERATIVE COMPLICATIONS;

ANAPHYLAXIS; ANESTHETICS; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS;

EID: 84966660706     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2016.02.024     Document Type: Short Survey

References (118)

1. [1] Mertes, P.M., Alla, F., Trechot, P., Auroy, Y., Jougla, E., Groupe d’études des réactions anaphylactoïdes P. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 128 (2011), 366–373.
2. [2] Tejedor Alonso, M.A., Moro Moro, M., Mugica Garcia, M.V., Epidemiology of anaphylaxis. Clin Exp Allergy 45 (2015), 1027–1039.
3. [3] Yu, J.E., Lin, R.Y., The epidemiology of anaphylaxis. Clin Rev Allergy Immunol, 2015 http://dx.doi.org/10.1007/s12016-015-8503-x.
4. [4] Simons, F.E., Ebisawa, M., Sanchez-Borges, M., Thong, B.Y., Worm, M., Tanno, L.K., et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. Epidemiology of anaphylaxis. World Allergy Org J, 8, 2015, 32.
5. [5] Faria, E., Rodrigues-Cernadas, J., Gaspar, A., Botelho, C., Castro, E., Lopes, A., et al. Drug-induced anaphylaxis survey in Portuguese Allergy Departments. J Investig Allergol Clin Immunol 24 (2014), 40–48.
6. [6] Mertes, P.M., Demoly, P., Malinovsky, J.M., Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol 12 (2012), 361–368.
7. [7] Laake, J.H., Rottingen, J.A., Rocuronium and anaphylaxis–a statistical challenge. Acta Anaesthesiol Scand 45 (2001), 1196–1203.
8. [8] McNeil, B.D., Pundir, P., Meeker, S., Han, L., Undem, B.J., Kulka, M., et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519 (2015), 237–241.
9. [9] Baldo, B.A., Fisher, M.M., Substituted ammonium ions as allergenic determinants in drug allergy. Nature 306 (1983), 262–264.
10. [10] Watkins, J., Udnoon, S., Taussig, P.E., Complement activation pathways and adverse (anaphylactoid) responses to i.v. anaesthetic agents [proceedings]. Br J Anaesth, 50, 1978, 73.
11. [11] Vignon, H., Gay, R., Laxenaire, M.C., Clinical observations of per- and post-anesthetic anaphylactoid complications. Results of an a posteriori survey. Ann Anesthesiol Fr 17 (1976), 117–121.
12. [12] Volcheck, G.W., Mertes, P.M., Local and general anesthetics immediate hypersensitivity reactions. Immunol Allergy Clin North Am 34 (2014), 525–546.
13. [13] Takazawa, T., Mitsuhata, H., Mertes, P.M., Sugammadex and rocuronium-induced anaphylaxis. J Anesth 30:2 (2016), 290–297 http://dx.doi.org/10.1007/s00540-015-2105-x.
14. [14] Mertes, P.M., Alla, F., Trechot, P., Auroy, Y., Jougla, E., Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 128 (2011), 366–373.
15. [15] Dong, S.W., Mertes, P.M., Petitpain, N., Hasdenteufel, F., Malinovsky, J.M., Gerap. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005–2007). Minerva Anestesiol 78 (2012), 868–878.
16. [16] Harboe, T., Guttormsen, A.B., Irgens, A., Dybendal, T., Florvaag, E., Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 102 (2005), 897–903.
17. [17] Reddy, J.I., Cooke, P.J., van Schalkwyk, J.M., Hannam, J.A., Fitzharris, P., Mitchell, S.J., Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology 122 (2015), 39–45.
18. [18] Mirone, C., Preziosi, D., Mascheri, A., Micarelli, G., Farioli, L., Balossi, L.G., et al. Identification of risk factors of severe hypersensitivity reactions in general anaesthesia. Clin Mol Allergy, 13, 2015, 11.
19. [19] Antunes, J., Kochuyt, A.M., Ceuppens, J.L., Perioperative allergic reactions: experience in a Flemish referral centre. Allergol Immunopathol 42 (2014), 348–354.
20. [20] Sadleir, P.H., Clarke, R.C., Bunning, D.L., Platt, P.R., Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 110 (2013), 981–987.
21. [21] Lobera, T., Audicana, M.T., Pozo, M.D., Blasco, A., Fernandez, E., Canada, P., et al. Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain. J Investig Allergol Clin Immunol 18 (2008), 350–356.
22. [22] Gurrieri, C., Weingarten, T.N., Martin, D.P., Babovic, N., Narr, B.J., Sprung, J., et al. Allergic reactions during anesthesia at a large United States referral center. Anesth Analg 113 (2011), 1202–1212.
23. [23] Garvey, L.H., Roed-Petersen, J., Menne, T., Husum, B., Danish Anaesthesia Allergy Centre - preliminary results. Acta Anaesthesiol Scand 45 (2001), 1204–1209.
24. [24] Garvey, L.H., Kroigaard, M., Poulsen, L.K., Skov, P.S., Mosbech, H., Venemalm, L., et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 120 (2007), 409–415.
25. [25] Low, A.E., McEwan, J.C., Karanam, S., North, J., Kong, K.L., Anaesthesia-associated hypersensitivity reactions: seven years’ data from a British bi-specialty clinic. Anaesthesia 71 (2016), 76–84.
26. [26] Reitter, M., Petitpain, N., Latarche, C., Cottin, J., Massy, N., Demoly, P., et al. Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis. Allergy 69 (2014), 954–959.
27. [27] Mitsuhata, H., Hasegawa, J., Matsumoto, S., Ogawa, R., The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan: a survey with a questionnaire of 529 hospitals approved by Japan Society of Anesthesiology. Masui 41 (1992), 1825–1831.
28. [28] Hepner, D.L., Castells, M.C., Anaphylaxis during the perioperative period. Anesth Analg 97 (2003), 1381–1395.
29. [29] Gibbs, N.M., Sadleir, P.H., Clarke, R.C., Platt, P.R., Survival from perioperative anaphylaxis in Western Australia 2000–2009. Br J Anaesth 111 (2013), 589–593.
30. [30] Light, K.P., Lovell, A.T., Butt, H., Fauvel, N.J., Holdcroft, A., Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?. Pharmacoepidemiol Drug Safety 15 (2006), 151–160.
31. [31] Paton, W.D., Histamine release by compounds of simple chemical structure. Pharmacol Rev 9 (1957), 269–328.
32. [32] Jerums, G., Whittingham, S., Wilson, P., Anaphylaxis to suxamethonium. A case report. Br J Anaesth 39 (1967), 73–77.
33. [33] Doenicke, A., Moss, J., Lorenz, W., Hoernecke, R., Gottardis, M., Are hypotension and rash after atracurium really caused by histamine release?. Anesth Analg 78 (1994), 967–972.
34. [34] Doenicke, A.W., Czeslick, E., Moss, J., Hoernecke, R., Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration. Anesth Analg 87 (1998), 434–438.
35. [35] Florvaag, E., Johansson, S.G., Oman, H., Venemalm, L., Degerbeck, F., Dybendal, T., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 49 (2005), 437–444.
36. [36] Guyer, A.C., Saff, R.R., Conroy, M., Blumenthal, K.G., Camargo, C.A. Jr., Long, A.A., et al. Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia. J Allergy Clin Immunol 3 (2015), 94–100 [In practice].
37. [37] Gonzalez-Estrada, A., Pien, L.C., Zell, K., Wang, X.F., Lang, D.M., Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States. J Allergy Clin Immunol, 3, 2015 [In practice. 101 e1-105 e1].
38. [38] Gueant, J.L., Mata, E., Namour, F., Romano, A., Aimone-Gastin, I., Kanny, G., et al. Criteria of evaluation and of interpretation of Sepharose drug IgE-RIA to anaesthetic drugs. Allergy 54:58 (1999), 17–22.
39. [39] Hasdenteufel, F., Luyasu, S., Hougardy, N., Fisher, M., Boisbrun, M., Mertes, P.M., et al. Structure-activity relationships and drug allergy. Curr Clin Pharmacol 7 (2012), 15–27.
40. [40] Mertes, P.M., Aimone-Gastin, I., Gueant-Rodriguez, R.M., Mouton-Faivre, C., Audibert, G., O'Brien, J., et al. Hypersensitivity reactions to neuromuscular blocking agents. Curr Pharm Des 14 (2008), 2809–2825.
41. [41] Mertes, P.M., De Blay, F., Dong, S., Allergic risk in anaesthesia. Presse Med 42 (2013), 269–279.
42. [42] Mertes, P.M., Volcheck, G.W., Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same. Anesthesiology 122 (2015), 5–7.
43. [43] Fisher, M., Baldo, B.A., Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesthesiol 11 (1994), 263–284.
44. [44] Mertes, P.M., Laxenaire, M.C., Alla, F., Groupe d’études des réactions anaphylactoïdes P. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 99 (2003), 536–545.
45. [45] Guttormsen, A.B., Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 45 (2001), 1189–1190.
46. [46] Dong, S., Acouetey, D.S., Gueant-Rodriguez, R.M., Zmirou-Navier, D., Remen, T., Blanca, M., et al. Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers. Clin Exp Allergy 43 (2013), 1256–1262.
47. [47] Florvaag, E., Johansson, S.G., The pholcodine case. Cough medicines, IgE-sensitization, and anaphylaxis: a devious connection. World Allergy Org J 5 (2012), 73–78.
48. [48] Florvaag, E., Johansson, S.G., Irgens, A., de Pater, G.H., IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 66 (2011), 955–960.
49. [49] Baldo, B.A., Fisher, M.M., Harle, D.G., Allergy to thiopentone. Clin Rev Allergy 9 (1991), 295–308.
50. [50] Moscicki, R.A., Sockin, S.M., Corsello, B.F., Ostro, M.G., Bloch, K.J., Anaphylaxis during induction of general anesthesia: subsequent evaluation and management. J Allergy Clin Immunol 86 (1990), 325–332.
51. [51] Clarke, R.S., Epidemiology of adverse reactions in anaesthesia in the United Kingdom. Klin Wochenschr 60 (1982), 1003–1005.
52. [52] Baker, M.T., Naguib, M., Propofol: the challenges of formulation. Anesthesiology 103 (2005), 860–876.
53. [53] Murphy, A., Campbell, D.E., Baines, D., Mehr, S., Allergic reactions to propofol in egg-allergic children. Anesth Analg 113 (2011), 140–144.
54. [54] Asserhoj, L.L., Mosbech, H., Kroigaard, M., Garvey, L.H., No evidence for contraindications to the use of propofol in adults allergic to egg, soy or peanutdagger. Br J Anaesth 116 (2016), 77–82.
55. [55] Mertes, P.M., Malinovsky, J.M., Jouffroy, L., Aberer, W., et al., Working Group of the S Sfa. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 21 (2011), 442–453.
56. [56] Ebo, D.G., Fisher, M.M., Hagendorens, M.M., Bridts, C.H., Stevens, W.J., Anaphylaxis during anaesthesia: diagnostic approach. Allergy 62 (2007), 471–487.
57. [57] Baldo, B.A., Pham, N.H., Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two. Anaesth Intensive Care 40 (2012), 216–235.
58. [58] Bhole, M.V., Manson, A.L., Seneviratne, S.L., Misbah, S.A., IgE-mediated allergy to local anaesthetics: separating fact from perception: a UK perspective. Br J Anaesth 108 (2012), 903–911.
59. [59] Laxenaire, M.C., Moneret-Vautrin, D.A., Widmer, S., Mouton, C., Gueant, J.L., Bonnet, M.C., et al. Anesthetics responsible for anaphylactic shock. A French multicenter study. Ann Fr Anesth Reanim 9 (1990), 501–506.
60. [60] Christiansen, I.S., Kroigaard, M., Mosbech, H., Skov, P.S., Poulsen, L.K., Garvey, L.H., Clinical and diagnostic features of perioperative hypersensitivity to cefuroxime. Clin Exp 45 (2015), 807–814.
61. [61] Blaabjerg, M.S., Andersen, K.E., Bindslev-Jensen, C., Mortz, C.G., Decrease in the rate of sensitization and clinical allergy to natural rubber latex. Contact Dermatitis 73 (2015), 21–28.
62. [62] Krishna, M.T., York, M., Chin, T., Gnanakumaran, G., Heslegrave, J., Derbridge, C., et al. Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase. Clin Exp Immunol 178 (2014), 399–404.
63. [63] Ohtoshi, T., Yamauchi, N., Tadokoro, K., Miyachi, S., Suzuki, S., Miyamoto, T., et al. IgE antibody-mediated shock reaction caused by topical application of chlorhexidine. Clin Allergy 16 (1986), 155–161.
64. [64] Beaudouin, E., Kanny, G., Morisset, M., Renaudin, J.M., Mertes, M., Laxenaire, M.C., et al. Immediate hypersensitivity to chlorhexidine: literature review. Eur Ann Allergy Clin Immunol 36 (2004), 123–126.
65. [65] Parkes, A.W., Harper, N., Herwadkar, A., Pumphrey, R., Anaphylaxis to the chlorhexidine component of Instillagel: a case series. Br J Anaesth 102 (2009), 65–68.
66. [66] Guleri, A., Kumar, A., Morgan, R.J., Hartley, M., Roberts, D.H., Anaphylaxis to chlorhexidine-coated central venous catheters: a case series and review of the literature. Surg Infect 13 (2012), 171–174.
67. [67] Opstrup, M.S., Johansen, J.D., Garvey, L.H., Chlorhexidine allergy: sources of exposure in the health-care setting. Br J Anaesth 114 (2015), 704–705.
68. [68] Eldrageely, K., Vargas, M.P., Khalkhali, I., Venegas, R., Burla, M., Gonzalez, K.D., et al. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue. Am Surg 70 (2004), 872–875.
69. [69] Giladi, A.M., Kasten, S.J., Anaphylactic-like reaction to methylene blue: case report and review of perioperative hypersensitivity reactions. Plast Reconstr Surg 130 (2012), 98e–105e.
70. [70] Mertes, P.M., Demoly, P., Alperovitch, A., Bazin, A., Bienvenu, J., Caldani, C., et al. Methylene blue-treated plasma: an increased allergy risk?. J Allergy Clin Immunol 130 (2012), 808–812.
71. [71] Mertes, P.M., Malinovsky, J.M., Mouton-Faivre, C., Bonnet-Boyer, M.C., Benhaijoub, A., Lavaud, F., et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 122 (2008), 348–352.
72. [72] Laxenaire, M.C., Charpentier, C., Feldman, L., Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 13 (1994), 301–310.
73. [73] Royston, D., The current place of aprotinin in the management of bleeding. Anaesthesia 70:1 (2015), 46e17–46e19.
74. [74] Schulze, K., Graeter, T., Schaps, D., Hausen, B., Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement. Eur J Cardiothorac Surg 7 (1993), 495–496.
75. [75] Dietrich, W., Spath, P., Zuhlsdorf, M., Dalichau, H., Kirchhoff, P.G., Kuppe, H., et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 95 (2001), 64–71 [discussion 5A–6A].
76. [76] Baldo, B.A., Sugammadex and hypersensitivity. Anaesth Intensive Care 42 (2014), 525–527.
77. [77] Tsur, A., Kalansky, A., Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia 69 (2014), 1251–1257.
78. [78] Takazawa, T., Tomita, Y., Yoshida, N., Tomioka, A., Horiuchi, T., Nagata, C., et al. Three suspected cases of sugammadex-induced anaphylactic shock. BMC Anesthesiol, 14, 2014, 92.
79. [79] Sadleir, P.H., Russell, T., Clarke, R.C., Maycock, E., Platt, P.R., Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anaesth Intensive Care 42 (2014), 93–96.
80. [80] Takazawa, T., Horiuchi, T., Yoshida, N., Yokohama, A., Saito, S., Flow cytometric investigation of sugammadex-induced anaphylaxis. Br J Anaesth 114 (2015), 858–859.
81. [81] Baldo, B., Sugammadex and rocuronium-induced anaphylaxis. Anaesthesia 67 (2012), 1174–1175 [author reply 5].
82. [82] Leysen, J., Bridts, C.H., De Clerck, L.S., Ebo, D.G., Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 66 (2011), 526–527.
83. [83] Clarke, R.C., Sadleir, P.H., Platt, P.R., The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 67 (2012), 266–273.
84. [84] Baldo, B.A., McDonnell, N.J., Sugammadex and anaphylaxis in the operating theater. Rev Esp Anestesiol Reanim 61 (2014), 239–245.
85. [85] Platt, P.R., Clarke, R.C., Johnson, G.H., Sadleir, P.H., Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case-control study. Anaesthesia 70 (2015), 1264–1267.
86. [86] Savic, L.C., Kaura, V., Yusaf, M., Hammond-Jones, A.M., Jackson, R., Howell, S., et al. Incidence of suspected perioperative anaphylaxis: a multicenter snapshot study. J Allergy Clin Immunol, 3, 2015 [In practice. 454 e1–5 e1].
87. [87] Cho, Y.J., Ju, J.W., Sim, H., Lee, J.H., Hong, D.M., Kim, T.K., et al. Intraoperative anaphylaxis to neuromuscular blocking agents: the incidence over 9 years at two tertiary hospitals in South Korea: a retrospective observational study. Eur J Anaesthesiol, 33(5), 2016 http://dx.doi.org/10.1097/EJA.0000000000000373.
88. [88] Opstrup, M.S., Malling, H.J., Kroigaard, M., Mosbech, H., Skov, P.S., Poulsen, L.K., et al. Standardized testing with chlorhexidine in perioperative allergy–a large single-centre evaluation. Allergy 69 (2014), 1390–1396.
89. [89] Chong, Y.Y., Caballero, M.R., Lukawska, J., Dugue, P., Anaphylaxis during general anaesthesia: one-year survey from a British allergy clinic. Singapore Med J 49 (2008), 483–487.
90. [90] Charuluxananan, S., Punjasawadwong, Y., Suraseranivongse, S., Srisawasdi, S., Kyokong, O., Chinachoti, T., et al. The Thai Anesthesia Incidents Study (THAI Study) of anesthetic outcomes: II. Anesthetic profiles and adverse events. J Med Assoc Thai 88:7 (2005), S14–S29.
91. [91] Mertes, P.M., Laxenaire, M.C., Gerap. Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001–December 2002). Ann Fr Anesth Reanim 23 (2004), 1133–1143.
92. [92] Escolano, F., Valero, A., Huguet, J., Baxarias, P., de Molina, M., Castro, A., et al. Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996–7). Rev Esp Anestesiol Reanim 49 (2002), 286–293.
93. [93] Laxenaire, M.C., Mertes, P.M., Groupe d’études des réactions anaphylactoïdes P. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 87 (2001), 549–558.
94. [94] Laxenaire, M.C., Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994–December 1996). Ann Fr Anesth Reanim 18 (1999), 796–809.
95. [95] Thacker, M.A., Davis, F.M., Subsequent general anaesthesia in patients with a history of previous anaphylactoid/anaphylactic reaction to muscle relaxant. Anaesth Intensive Care 27 (1999), 190–193.
96. [96] Dietrich, W., Spath, P., Ebell, A., Richter, J.A., Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 113 (1997), 194–201.
97. [97] Dormans, J.P., Templeton, J., Schreiner, M.S., Delfico, A.J., Intraoperative latex anaphylaxis in children: classification and prophylaxis of patients at risk. J Pediatr Orthop 17 (1997), 622–625.
98. [98] Tan, B.B., Lear, J.T., Watts, J., Jones, P., English, J.S., Perioperative collapse: prevalence of latex allergy in patients sensitive to anaesthetic agents. Contact Dermatitis 36 (1997), 47–50.
99. [99] Laxenaire, M.C., Substances responsible for peranesthetic anaphylactic shock. A third French multicenter study (1992–94). Ann Fr Anesth Reanim 15 (1996), 1211–1218.
100. [100] Kwittken, P.L., Sweinberg, S.K., Campbell, D.E., Pawlowski, N.A., Latex hypersensitivity in children: clinical presentation and detection of latex-specific immunoglobulin E. Pediatrics 95 (1995), 693–699.
101. [101] Pepys, J., Pepys, E.O., Baldo, B.A., Whitwam, J.G., Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthesia 49 (1994), 470–475.
102. [102] Pecquet, C., Leynadier, F., IgE mediated allergy to natural rubber latex in 100 patients. Clin Rev Allergy 11 (1993), 381–384.
103. [103] Clarke, R.S., Watkins, J., Drugs responsible for anaphylactoid reactions in anaesthesia in the United Kingdom. Ann Fr Anesth Reanim 12 (1993), 105–108.
104. [104] Laxenaire, M.C., Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 12 (1993), 91–96.
105. [105] Currie, M., Webb, R.K., Williamson, J.A., Russell, W.J., Mackay, P., The Australian Incident Monitoring Study. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 21 (1993), 621–625.
106. [106] Mitsuhata, H., Matsumoto, S., Hasegawa, J., The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui 41 (1992), 1664–1669.
107. [107] Binkley, K., Cheema, A., Sussman, G., Moudgil, G., O'Connor, M., Evans, S., et al. Generalized allergic reactions during anesthesia. J Allergy Clin Immunol 89 (1992), 768–774.
108. [108] Assem, E.S., Anaphylactic anaesthetic reactions. The value of paper radioallergosorbent tests for IgE antibodies to muscle relaxants and thiopentone. Anaesthesia 45 (1990), 1032–1038.
109. [109] Watkins, J., Second report from an anaesthetic reactions advisory service. Anaesthesia 44 (1989), 157–159.
110. [110] Watkins, J., Adverse anaesthetic reactions. An update from a proposed national reporting and advisory service. Anaesthesia 40 (1985), 797–800.
111. [111] Galletly, D.C., Treuren, B.C., Anaphylactoid reactions during anaesthesia. Seven years’ experience of intradermal testing. Anaesthesia 40 (1985), 329–333.
112. [112] Leynadier, F., Luce, H., Dry, J., Anaphylactoid accidents during general anesthesia. Apropos of 55 cases. Sem Hop 60 (1984), 1029–1033.
113. [113] Youngman, P.R., Taylor, K.M., Wilson, J.D., Anaphylactoid reactions to neuromuscular blocking agents: a commonly undiagnosed condition?. Lancet 2 (1983), 597–599.
114. [114] Vervloet, D., Nizankowska, E., Arnaud, A., Senft, M., Alazia, M., Charpin, J., Adverse reactions to suxamethonium and other muscle relaxants under general anesthesia. J Allergy Clin Immunol 71 (1983), 552–559.
115. [115] Laxenaire, M.C., Moneret-Vautrin, D.A., Boileau, S., Moeller, R., Adverse reactions to intravenous agents in anaesthesia in France. Klin Wochenschr 60 (1982), 1006–1009.
116. [116] Sage, D., Intradermal drug testing following anaphylactoid reactions during anaesthesia. Anaesth Intensive Care 9 (1981), 381–386.
117. [117] Fisher, M.M., More, D.G., The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 9 (1981), 226–234.
118. [118] Clarke, R.S., Dundee, J., Garrett, F.T., McArdle, G.K., Sutton, J.A., Adverse reactions to intravenous anaesthetics. Br J Anaesth 47 (1975), 575–585.